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Abstract 
Approximately 25 % of individuals with Crohn's disease (CD), a life-long relapsing-remitting disease, are 
diagnosed during childhood and adolescence. Symptoms of CD, including abdominal pain, nausea and 
diarrhoea, can lead to reduced food intake, which may negatively have an impact on nutritional status 
during this critical period of growth and development. The aims of the present study were to assess the 
growth and adequacy of dietary intakes of children with CD at Sydney Children's Hospital, Randwick, and 
compare with healthy controls. Sixty-three subjects aged 10–16 years were recruited, including: children 
with active CD (n 18), children with CD in remission (n 23) and healthy controls (n 22). Dietary intake was 
assessed using a FFQ and compared with current Australian recommended dietary intakes (RDI). Growth 
and dietary intakes were compared between groups. Subjects with active CD had lower weight and BMI Z 
scores than children in remission and controls. The energy intakes of children with active CD and those in 
remission were significantly lower than estimated energy requirements (P = 0·001 and P = 0·03 
respectively). Children with active CD did not meet the RDI for Fe and their Ca intake was lower than the 
RDI (P = 0·04). In conclusion, the dietary intake of children with active CD was impaired, with inadequate 
intakes of energy, Ca and Fe. Reduced energy intakes during active disease may contribute to poor weight 
gain and impaired growth. Quantifying nutrient intake and ascertaining requirements for nutritional 
supplementation are essential components of successful management in paediatric CD. 
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Approximately 25 % of individuals with Crohn’s disease (CD), a life-long relapsing-remitting disease, are diagnosed during childhood and
adolescence. Symptoms of CD, including abdominal pain, nausea and diarrhoea, can lead to reduced food intake, which may negatively have
an impact on nutritional status during this critical period of growth and development. The aims of the present study were to assess the growth
and adequacy of dietary intakes of children with CD at Sydney Children’s Hospital, Randwick, and compare with healthy controls. Sixty-three
subjects aged 10–16 years were recruited, including: children with active CD (n 18), children with CD in remission (n 23) and healthy controls
(n 22). Dietary intake was assessed using a FFQ and compared with current Australian recommended dietary intakes (RDI). Growth and dietary
intakes were compared between groups. Subjects with active CD had lower weight and BMI Z scores than children in remission and controls.
The energy intakes of children with active CD and those in remission were significantly lower than estimated energy requirements (P¼0·001
and P¼0·03 respectively). Children with active CD did not meet the RDI for Fe and their Ca intake was lower than the RDI (P¼0·04).
In conclusion, the dietary intake of children with active CD was impaired, with inadequate intakes of energy, Ca and Fe. Reduced energy intakes
during active disease may contribute to poor weight gain and impaired growth. Quantifying nutrient intake and ascertaining requirements for
nutritional supplementation are essential components of successful management in paediatric CD.
Children: Crohn’s disease: Inflammatory bowel disease: Diet: Nutrition
Crohn’s disease (CD) is a type of inflammatory bowel disease
(IBD) involving chronic inflammation of any region of the
gastrointestinal tract. It is a life-long disease without cure
and cycles through periods of remission and relapse (active
disease)(1). Its aetiology is suspected to be an uncontrolled
immune response to endogenous or exogenous triggers as a
result of genetic and/or other modifying factors(2). CD often
presents during childhood and adolescence, with this age
group accounting for 25 % of newly diagnosed cases of
IBD(2). Paediatric CD prevalence has increased around the
world over the past few years, particularly during the period
of late childhood and adolescence(3).
Inflammation of the gastrointestinal tract and the related
symptoms of pain, nausea and diarrhoea, as seen in CD,
often lead to a loss of appetite and reduced food intake(4).
Bowel-wall thickening may lead to obstruction and contribute
to pain as food is digested. As a result, children often
experience early satiety and decrease their oral intake to
avoid these symptoms, on both conscious and subconscious
levels(5). Malnutrition is most common in the acute phases
of CD(4); however, it has also been documented during periods
of remission(6).
The nutritional inadequacies of reduced food intakes are
intensified by the increased energy and nutrient requirements
related to disease activity and the increased requirements
during childhood and adolescence for healthy growth and
development(5). Consequent to poor dietary intake in these
children, micronutrient deficiencies are commonly seen.
These include Ca, Fe, Zn, Mg(7), vitamin D(8), folate(9) and
vitamin B12
(10) deficiencies. Reduced food intake in addition
to malabsorption and increased intestinal losses of essential
nutrients associated with inflammation may lead to chronic
undernutrition in paediatric CD(5).
Reduced energy intake, increased weight loss and impaired
linear growth in paediatric CD are associated with low lean
body mass and chronic inflammation during disease
activity(11). This can lead to a lower ideal body weight in
children with CD(12) and affect the final height achieved,
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especially when diagnosis is made during childhood and early
adolescence(11). Dietary intakes vary during the course of the
disease depending on the severity and associated symptoms,
where oral intake is reduced during active phases of CD,
and increased during periods of remission(13).
Decreased bone mineral density and increased risk for devel-
oping osteopenia are also commonly identified in children and
adolescents with CD(14,15). An inadequate dietary intake of
specific nutrients is one of the proposed mechanisms responsible
for increased osteoporotic risk in these children, in addition to
malabsorption of Ca and vitamin D. Hormonal and genetic
factors may also contribute as well as specific therapies (such
as corticosteroids that may reduce Ca absorption)(16).
The aims of the present study were to assess the dietary
intakes of children with CD at Sydney Children’s Hospital
(Randwick, Sydney, Australia) in comparison with Australian
recommended dietary intakes (RDI) and to determine if
dietary intakes were affected by CD activity. Additionally,
the present study aimed to compare growth and dietary intakes
of children with CD with healthy controls.
Materials and methods
Subjects
Sixty-three subjects aged between 10 and 16 years were
recruited. This included children with active CD (n 18), CD
in remission (n 23) and healthy controls (n 22). Remission
was classified as having a paediatric Crohn’s disease activity
index (PCDAI) score of less than 15; not in remission
(active disease) was defined as a PCDAI of 15 or higher(17).
The PCDAI is a validated instrument that assesses a
combination of objective and subjective factors, including
common laboratory tests, reported abdominal pain, growth
parameters and history, to determine disease activity in
paediatric CD(17). All forty-one children with CD attended
the IBD Clinic at Sydney Children’s Hospital between
November 2006 and December 2007 and were part of an
ongoing prospective study to investigate the mechanisms of
diminished bone strength in childhood IBD.
Healthy control subjects were recruited from out-patient
clinics and the Ambulatory Care unit at Sydney Children’s
Hospital during August and September 2007. Control subjects
were excluded if they had any underlying gastrointestinal
disease or a medical condition requiring a specialised or
restricted diet.
Weight, height and age were recorded at the time of
recruitment. Patients were weighed wearing light clothing
and no shoes on the same calibrated digital scales to the
nearest 0·1 kg. Height was measured to the nearest 0·1 cm
using the same fixed, calibrated stadiometer. BMI was
calculated using available weight and height measurements.
Age- and sex-specific SD scores (Z scores) for weight, height
and BMI were calculated using Epi Info (version 3.4.1, 2007;
Centers for Disease Control and Prevention, Atlanta, GA, USA).
The present study was conducted according to the guide-
lines laid down in the Declaration of Helsinki. All procedures
involving patients were approved by the South East Sydney
Illawarra Area Health Service Research Ethics Committee.
Written informed consent was obtained from all subjects or
their parents.
Food-frequency questionnaire
Usual dietary intake was assessed for all subjects using a
sixty-item FFQ based on data from the 1995 Australian
National Nutrition Survey (NNS)(18). The food items were
described in household portions (for example, slice of bread,
tub of yoghurt), derived from median portions of common
foods consumed by 12- to 15-year olds in the 1995 NNS(18).
Portion sizes were able to be changed by subjects if they
did not reflect their usual intake. Verbal instruction of
FFQ completion and a written example were provided
before self-administration of the questionnaire. Parents
assisted their child to complete the questionnaire. The study
investigator checked all questionnaires for completeness and
clarified doubtful responses with both parent and child upon
return of the questionnaire. The FFQ assessed the previous
week’s intake by indicating how frequently each food item
was consumed in times/d per week. Vitamin and mineral
supplementation was not recorded.
The FFQ used was obtained, with permission, from the
authors of a recent study assessing the dietary intakes of Ca,
energy and fat in adolescents aged 12–16 years(19). Slight
modifications were made to the original FFQ relevant to the
purpose of the present study, including the addition of
commercially available oral nutrition supplements that are
commonly consumed by children attending the IBD clinic.
Data analysis
Differences in age between the groups were assessed by
ANOVA and differences by sex assessed by the Fisher exact
probability test. Data from the FFQ were manually entered
into FoodWorks nutrient analysis software (V5.00.1369,
Professional Edition, 2007; Xyris Software (Australia) Pty
Ltd, Highgate Hill, Queensland, Australia). Demographic
data and nutrient analysis data were then transferred and
analysed using SPSS for Windows (version 15.0, 2007;
SPSS Inc., Chicago, IL, USA). Significance between group
means was set at the 0·05 level.
Within-group comparison. Estimated energy requirements
(EER) were calculated by the method outlined in the Nutrient
Reference Values for Australia and New Zealand (20).
This method uses the Schofield equation(21), namely:
EER ¼ ð0·074 ðwtÞ þ 2·754Þ £ PAL þ GF in males;
EER ¼ ð0·056 ðwtÞ þ 2·898Þ £ PAL þ GF in females;
where PAL is physical activity level and GF is a growth factor.
Individual subject weights (wt) in kg were entered into the
equation. The PAL used for all subjects was ‘light’
(PAL ¼ 1·6) and the standard GF used was 105 kJ/d for
individuals aged between 9 and 18 years to include the extra
energy required for normal growth(20). This GF was
established by the National Health and Medical Research Coun-
cil (NHMRC) based on research by Butte et al. (22) who esti-
mated the energy content of tissue deposition, and Guo
et al. (23) who established the 50th percentile for healthy
weight gain at different ages.
Individual energy intakes taken from the FoodWorks
analysis were compared as a percentage with EER. Similarly,
dietary intakes of protein, Ca, Fe and Zn were compared as a

















percentage with RDI(20). One-sample t tests were used to com-
pare group mean percentage intake with EER/RDI using a test
value of 100.
Between-group comparison. One-way ANOVA was used
to compare intake of nutrients among the three groups, with
post hoc analysis using Tukey’s test to determine the signifi-
cance of the mean difference between groups. Variables of
interest included total energy intake, energy intake as a
percentage of EER, protein, Ca, Fe and Zn intake as a percen-
tage of RDI and the intake of protein, fat, carbohydrate (g),
and their percentage of contribution to total energy intake
(kJ). This method was also used to compare growth by testing
weight, height and BMI Z scores for statistical difference
between the three groups. Further analysis was also
undertaken using linear regression, where active CD was
coded as 0, inactive CD coded as 1 and controls coded as 2,
to establish if there were any associations between groups.
Results
The three groups were of similar age and sex (P¼0·4 for age
and P¼0·8 for sex). Ages and sex were 12·94 (SD 1·51) years
in active CD (six males, twelve females), 13·65 (SD 1·95)
years in CD in remission (fifteen males, eight females) and
13·59 (SD 2·11) years in healthy controls (twelve males, ten
females). Mean Z scores for weight, height and BMI for
active CD were all below the reference population mean,
and were lower than children with CD in remission and
controls (Fig. 1). Significant differences in weight Z scores
were found between subjects with active CD and controls
(P¼0·04; Tukey’s test). In addition, there was a significant
association in weight Z scores between the groups, with
subjects with active CD having the lowest weight Z scores,
followed by those with CD in remission and controls with
the highest weight Z scores (b 0·300; P¼0·017). Height
Z scores did not differ significantly between groups
(P.0·05) by ANOVA. However, there was a significant
association between the groups for BMI Z scores by linear
regression (b 0·235; P¼0·045).
The energy intakes (compared with EER) and intakes of
protein, Ca, Fe and Zn (compared with RDI) of each group
were compared (Fig. 2). Group averages show that no group
met the EER; however, energy intake was lowest in the
children with active CD. All children with CD had energy
intakes significantly lower than EER (active CD, P¼0·001;
CD in remission, P¼0·03; Tukey’s test); however, there was
no association between the groups by linear regression.
Total energy intakes of children with active CD were signifi-
cantly lower than controls (P¼0·047; Tukey’s test; Table 1).
All groups on average consumed less than the RDI for Ca.
However, the difference was only statistically significant for
children with active CD (P¼0·04) and no association was
found with linear regression. All subjects exceeded protein
and Zn requirements. There was an association between the
three groups for protein intake using linear regression
(b 0·249; P¼0·049) but no association for Zn. Fe intake
was adequate for CD subjects in remission and controls.
Although not statistically significant by ANOVA or linear
regression, subjects with active CD did not meet the RDI
for Fe (86·3 (SD 49·5) % of RDI).
No difference was found in the percentage of energy intake
from protein (P¼0·83), fat (P¼0·22) or carbohydrate
(P¼0·37) between groups (Table 1). However, all macronutri-
ent intakes (in g) were lower in active CD subjects, compared
with children with CD in remission and controls.
Carbohydrate intake was found to be significantly lower
(P¼0·03) in children with active CD compared with controls.
Intake of fat in children with active CD compared with
controls approached statistical significance (P¼0·06), whereas
protein intake was similar (P¼0·09) between the two groups.
Fig. 1. Comparison of weight, height and BMI Z scores between groups:
children with active Crohn’s disease (CD; B); children with CD in remission
( ); controls (A). Values are means, with standard errors represented by
vertical bars. * Mean value was significantly different from that of the control
group (P¼0·04). There was also a significant association between groups for
weight Z scores (b 0·300; P¼0·017) and BMI Z scores (b 0·253; P¼0·045)
by linear regression.
Fig. 2. Intakes of energy in comparison with estimated energy requirement
(EER; - - -) and intakes of protein, Ca, Fe and Zn in comparison with
recommended dietary intake (RDI; - - -) by group: children with active Crohn’s
disease (CD; B); children with CD in remission ( ); controls (A). Values
are means, with standard errors represented by vertical bars. Mean value
was significantly different from that of the control group: *P¼0·04,
**P¼0·03, ***P¼0·001. There was a significant association between the
groups for protein intake by linear regression analysis (b 0·249; P¼0·049)
but not for any other nutrient.

















Macronutrient intakes were similar between children with CD
in remission and controls.
No difference was observed between groups for intakes of
energy, protein, Ca, Fe and Zn. However, when comparing the
intakes of children with active CD (as a percentage of EER
and RDI) with those with CD in remission and controls, there
was a trend for the total energy and Fe intakes to be lower (Fig. 2).
Discussion
An important finding of the present study was that the dietary
intake of children with active CD was inadequate. Children
with active CD had significantly reduced energy intakes
compared with EER, a likely consequence of reduced food
consumption. The significantly lower weight and BMI Z score
(Fig. 1) and inadequate intake of Ca (Fig. 2) in children with
active CD are likely to be a result of reduced energy intake.
All energy intakes among the three groups were below
EER, which suggests that the Schofield equation used may
not accurately estimate EER. The Schofield equation (with
weight variable only) has been shown to overestimate resting
energy expenditure (REE) in healthy paediatric populations in
comparison with other equations(24,25). However, the NHMRC
EER equation(20), based on the Schofield equation, was
applied to the present study for consistency of results.
The PAL employed (1·6) may have contributed to the consist-
ent overestimation of EER, and a PAL of 1·3 used by Filippi
et al. (6) may have reduced the impact of this PAL. Addition-
ally, the importance of a PAL is limited in the present study,
since physical activity was not determined on an individual
basis. Use of lean body mass as the primary variable in a
REE prediction equation, as opposed to weight in the
Schofield equation, may increase the accuracy of REE
estimation in these children.
The lower energy intake observed in the active CD group
compared with controls is consistent with the established
literature(26,27). Thomas et al. (9) found that children with
active CD had an energy intake deficit of 1764 kJ compared
with controls; however, energy intake was normal during
remission. Hendricks et al. (7) reported decreased energy
intake in paediatric CD, which is suggested to be the key
factor responsible for weight loss in CD(28). Children with
CD have different energy requirements from healthy children,
such as an increased REE during remission, probably due to a
lower fat-free mass(29). Thus, an individual assessment of
energy balance may be required in children with CD.
A key finding of the present study shows that children with
active CD appeared to be growth impaired, with lower weight
Z scores compared with those in remission or controls (Fig. 1).
Further, there was an association with weight Z scores in that
children with active disease have the lowest scores followed
by children with CD in remission and then controls with the
highest weight Z scores. A similar association was also
found with BMI Z scores (Fig. 1). However, no significant
difference was found with the height Z scores. This is
consistent with the research of Burnham et al. (30), who
found children with a higher PCDAI (i.e. active CD) had a
reduced weight and lean tissue mass. The literature generally
illustrates impaired growth of children with CD, particularly
during periods of disease activity(11,14).
Interestingly, the results of the present study indicate that pro-
tein intake was adequate in children with CD, although children
with active CD had a lower protein intake compared with
inactive CD and controls as shown by the significant linear
regression result. Nevertheless, subjects with active CD had
impaired growth, which concurs with results by Hendricks
et al. (7), where growth stunting was seen despite adequate
protein intake in paediatric CD. Dietary protein is not an at-
risk nutrient in Westernised countries; however, due to the
increased demand during CD activity for normal growth and
development as well as enhanced requirements due to the
losses associated with chronic inflammation, protein consump-
tion may still be inadequate(31). It is thought that increased
intestinal and transcapillary losses are responsible for decreased
protein stores and reduced serum albumin in up to 80 % of CD
patients(5).
There was a tendency toward lower fat intakes in children
with active CD compared with those with CD in remission
or controls. Dietary fat intake is significantly linked with intes-
tinal mucosal events, suggesting a relationship between fat and
CD activity(13). Dietary fat consumption has been found to be
significantly lower in patients with CD(28) particularly during
periods of disease activity in combination with impaired
linear growth in childhood(7). Intakes of fat were similar
between children with CD in remission and controls
(Table 1), which is consistent with a study by Filippi et al. (6)
who reported no difference in macronutrient intake between
patients with CD in remission and controls. Other studies
have reported depleted fat intakes in children with CD(32)
Table 1. Total energy intakes and comparison of macronutrient intakes and their contribution to total energy between groups
(Mean values and standard deviations)
Active CD CD in remission Control
Mean SD Mean SD Mean SD ANOVA: P
Energy from protein (% total energy intake) 16·83 3·07 16·48 2·56 16·32 2·42 0·828
Energy from fat (% total energy intake) 32·50 2·98 34·39 4·08 32·68 4·34 0·220
Energy from CHO (% total energy intake) 50·56 4·42 49·13 4·37 51·05 5·23 0·374
Energy (kJ) 6556* 2959 8614 3384 9170 3658 0·047
Protein (g) 64·78 29·33 84·13 37·50 88·73 36·64 0·088
Fat (g) 59·22 29·82 82·35 37·74 83·73 35·55 0·057
CHO (g) 196·94* 85·36 248·48 89·81 282·50 111·87 0·026
CD, Crohn’s disease; CHO, carbohydrate.
* Mean value was significantly different from that of the control group (P,0·05; post hoc Tukey’s test).

















and adults with CD(10,28,33), particularly n-3 fatty acids, which
may have beneficial anti-inflammatory properties(34).
Carbohydrate was the only macronutrient found to be
consumed in a lower quantity by subjects with active CD
than controls (Table 1). Rigauld et al. (28) found a significantly
decreased intake of carbohydrate in patients with CD, whereas
Hendricks et al. (7) found no significant difference in
carbohydrate intake between children with CD and controls.
In contrast, children with CD have been shown to consume
significantly more carbohydrate than controls(35). The varied
results within the literature may be explained by the range
of geographical locations studied, and may suggest that
carbohydrate intake is not specifically linked with disease
activity. The percentage of macronutrient contribution to
total energy intake was similar between all groups, suggesting
that the lower intake of macronutrients is a direct consequence
of decreased food and energy intakes during active disease.
On average, no group met the RDI for Ca, which may be due to
the increased recommendation for Ca requirements in the new
nutrient reference values(20). The only group with a Ca intake
significantly lower than the RDI was the children with active
CD. This finding agrees with research by Hendricks et al. (7)
and Guerreiro et al. (35) where children with CD consumed sig-
nificantly less Ca than healthy controls. Poor dietary intakes of
Ca may negatively impact on bone strength, increasing the
osteoporotic risk in children with CD(36).
Fe is the most common micronutrient deficiency documen-
ted in paediatric CD, which partly stems from inadequate
intake; however, it is more likely due to poor absorption,
particularly in children with active small-bowel disease(5).
Children with active CD were the only group who did not
meet the RDI for Fe (86 % RDI), although this was not a
statistically significant finding. The present study focused
on dietary Fe intake and did not include the intake of Fe
(or other vitamin and mineral) supplements. Inclusion of sup-
plemental intakes would be useful in future studies, particu-
larly when comparing intakes with markers of Fe status. Zn
intake is also commonly reported to be low among the
IBD population(6,7); however, this was not observed in the
present study. High intakes of protein-containing foods,
which are also major sources of dietary Zn, could be a
reason for the adequate intakes of Zn observed in the
present study.
RDI are designed to be used as a goal for individual intake,
and have not been recommended to assess nutrient intake
among groups(20). However, since the present study aimed to
assess the dietary intake of children with CD who are unwell
and more critically require sufficient nutrient intake, RDI
were used as a means of comparing nutrient intake with rec-
ommendations. RDI were chosen since estimated average
requirements (EAR) are much lower for nutrients that are
already ‘at risk’ in this population, and consequently may
inadequately reflect their true requirements. Future studies of
this nature may benefit from comparing both RDI and EAR.
Although children with CD met RDI for protein and Zn,
actual absorption of these nutrients may be limited, especially
during disease activity and inflammation, since dietary intake
is just one factor that affects the nutritional status of children
with CD. Other confounding factors that affect nutritional
status include malabsorption, intestinal losses, corticosteroid
use and surgical resection(2,37).
The sample size of the present study limits the conclusions
that can be taken from these results. A further limitation of
the present study was the use of the NHMRC method of
estimating energy requirements(20) along with the inclusion
of a standard PAL. This may have caused some inconsisten-
cies with data from the previous literature. Additionally,
limited nutrients were analysed, since the FFQ was not
designed to accurately reflect dietary intakes of nutrients
other than those reported here. The use of weighed food
records would be beneficial in future studies to obtain a
more accurate assessment of actual dietary intake.
In conclusion, dietary intakes of children with active CD
were adversely affected. Reduced intake is a potential factor
having an impact upon weight gain and linear growth. Low
energy intake due to reduced food consumption is the primary
reason for inadequate intakes of Ca and Fe in children with
active CD. The results of the present study provide useful
information of the potential impact of diet upon overall
nutrient intake and growth in children with CD. Quantifying
nutrient intake in paediatric CD can help to determine the
extent to which nutrient supplementation and dietary
intervention is required in the management of CD (and
particularly active CD). An area of future research may be
to observe the frequency of food group intakes (such as
meat, dairy products, vegetables and fruit) to assess whether
poor nutrient intakes correlate with specific food avoidance.
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